Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin.
D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001702:Biopharmaceutics; D003864:Depression, Chemical; D004357:Drug Synergism; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008297:Male; D010243:Paralysis / Q000139:chemically induced; D010636:Phenols / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D015049:Zoxazolamine / Q000378:metabolism*
D000814:Aniline Compounds; D010636:Phenols; D010672:Phenytoin; D015049:Zoxazolamine